ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Kineta to Collaborate on the Development of a Novel Non-Opioid Pain Therapy with Genentech
April 17, 2018Kineta today announced that it has entered into an exclusive option and license agreement with Genentech, Inc., a member of the Roche Group, to develop Kineta's α9/α10 nicotinic acetylcholine receptor (nAChR) antagonists for the treatment of chronic pain.
Pharma Sources Insight January 2025
